Antiretroviral treatment and age‐related comorbidities in a cohort of older HIV‐infected patientsGiovanna Orlando, A. Cargnel, Paola Meraviglia et al.|HIV Medicine|2006Cited by 75
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?Velia Chiara Di Maio, L. Lambiase, Nicola Caporaso et al.|Journal of Hepatology|2017Cited by 31
Are direct-acting antivirals safe and effective in hepatitis C virus-cryoglobulinemia? virological, immunological, and clinical data from a real-life experienceMatteo Passerini, Giuliano Rizzardini, Monica Schiavini et al.|European Journal of Gastroenterology & Hepatology|2018Cited by 24
Four years of tenofovir monotherapy for NUC naïve field practice European patients suppresses HBV replication in most patients with a favorable renal safety profile but does not prevent HCC in patients with or without cirrhosisPietro Lampertico, M. Colombo, R. Soffredini et al.|Digestive and Liver Disease|2014Cited by 23
Fibrosis progression in paired liver biopsies from HIV/HCV co-infected patients.Monica Schiavini, G. Gubertini, Elena Angeli et al.|PubMed|2011Cited by 18